Topical drugs are the opposite of systemic medications and goods since they are typically administered to body surfaces like skin or mucous membranes. These drugs come in the form of lotions, ointments, creams, foams, gels, and other substances.

The deep penetration of medications in the body, the high frequency of skin illnesses and burn injuries, the growing preference for non-invasive topical drug administration, and the aging population are the main reasons driving the topical drug delivery market. However, the late start of action and adverse effects of topical medications, like rashes and allergies, limit the market’s expansion. In the near future, a number of prospects for market expansion are anticipated to be presented by factors like the acquisition of small market competitors and the delivery of biologics via transdermal route.

The product, method of administration, end user, and geographic segments of the topical medication delivery market are used for segmentation. It is divided into devices and formulations based on the product. Topical formulations are further divided into liquid, semisolid, and solid categories. Transdermal patches and transdermal gels are additional categories for devices. It is categorized into cutaneous, ocular, rectal, vaginal, and nasal routes of delivery. Home care settings, private clinics, and hospitals are included in the end-user segment. The market is examined geographically in the following regions: Asia-Pacific (Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), North America (U.S., Canada, and Mexico), and Latin America (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Research Methodology:

After secondary research provided a fundamental understanding of the worldwide Topical Drug Delivery Market Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Topical Drug Delivery Market Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.

Topical Drug Delivery Market Market based on Connectivity Product:

• Semi-Solid Formulations
• Liquid Formulations

Topical Drug Delivery Market Market based on Route Of Administration:

• Dermal
• Ophthalmic
• Nasal

Topical Drug Delivery Market Market based on Geography:

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
• Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

The industry has been subdivided into semi-solid formulations, liquid formulations, solid formulations, and transdermal products based on product types. Due to several strategic alliances and business expansion initiatives by industry participants, the semi-solid formulations type segment led the global industry in 2021 and generated the greatest revenue share (62.0%) of the total revenue. For example, Incyte and Maruho Co. Ltd. established a strategic cooperation in April 2022 to develop, produce, and sell ruxolitinib cream for the treatment of dermatological conditions.

Additionally, in June 2021, MedPharm Ltd. opened a manufacturing plant in North Carolina, expanding its CDMO capabilities to include semi-solid and liquid manufacture. In the upcoming years, these strategic measures should support industry growth. Because of the introduction of liquid formulations pharmaceuticals by major companies and the acquisition of cutting-edge technology, the liquid formulations drug segment is anticipated to grow at a profitable rate throughout the forecast period. For instance, Journey Medical Corp. and Vyne Therapeutics, Inc. inked a contract in January 2022 for Journey to purchase the latter’s Molecular Stabilizing Technology business. Amzeeq and Zilxi, two topical monocycline medications, are part of the franchise. Additionally, Zylo Therapeutics raised USD 5.22 million in June 2022 to accelerate the development of their Z-pod topical delivery particles.

The worldwide industry has been further divided into cutaneous drug delivery, ocular drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery based on the mode of administration. In 2021, the cutaneous drug delivery segment held a dominant position in the business, contributing over 53.70% of the worldwide revenue. The non-invasive nature, ease of application, and rising use of transdermal patches are the reasons behind this segment’s large revenue share. It is anticipated that the use of nicotine transdermal patches would rise in tandem with the number of tobacco smokers who are willing to stop.

For example, the Centers for Disease Control and Prevention (CDC) report that in 2021, almost sixty-five percent of young people who used tobacco products expressed a willingness to give them up completely. Over the course of the forecast period, it is expected that the dermal drug delivery sector will continue to grow at the quickest rate and maintain its leading position in the industry. The increased use of dermal medication delivery for the treatment of migraines and chronic pain is responsible for this growth. It is anticipated that the introduction of transdermal patches to treat chronic pain will accelerate the segment’s growth. Transdermal buprenorphine patches, for example, are used to treat persistent pain following surgery.

The industry has been further segmented into home care settings, hospitals & clinics, burn centers, and other facilities based on end-uses. During the projected years, the other facilities segment is predicted to grow at the quickest rate, with a CAGR of 10.15%. Product innovations and growing health consciousness are blamed for this. For example, the FDA authorized three topical medications in February 2020: Pataday Once/Twice Daily Relief drops for itchy or red eyes, and Voltaren arthritic Pain topical gel for momentary arthritic pain relief. With these approvals, it is anticipated that topical medicine use in diagnostic center settings would rise, propelling market growth in the years to come. However, in 2021, the hospitals & clinics category led the market and was responsible for the largest revenue share.

• This report illustrates the most vital attributes of the Topical Drug Delivery Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Topical Drug Delivery Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Topical Drug Delivery Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Topical Drug Delivery Market.